PHIO Q1 2020 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$45,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-93.67

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$43,000

Balance Sheet

Total Assets

$14M

Total Liabilities

$2M

Stockholders' Equity

$12M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$21,000	-100.0%
Gross Profit	-$45,000	-$1M	+95.8%
Operating Income	-$2M	-$2M	-9.8%
Net Income	-$2M	-$2M	-10.9%